⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NNVC News
NanoViricides Inc.
NanoViricides Dual Track Clinical Strategy Explained by a Research Report - Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses
accessnewswire.com
NNVC
NanoViricides, Inc. Has Filed its Annual Report
accessnewswire.com
NNVC
RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
accessnewswire.com
NNVC
NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
accessnewswire.com
NNVC